1 study found for:    21502083 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Valganciclovir to Reduce T Cell Activation in HIV Infection
Conditions: HIV Infections;   Cytomegalovirus Infections
Interventions: Drug: Valganciclovir;   Drug: Placebo

Indicates status has not been verified in more than two years